Find the latest business, financial, national and international news and cryptocurrency news, updates, values, price predictions, and more on Bitcoin, Etherium, Litecoin, Zcash, Dash, Ripple and others from Crypto Insider
BusinessGlobeNewswire
RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) reduces acquired resistance versus osimertinib in first-line EGFR-mutated advanced non-small cell lung cancer
New data demonstrate amivantamab combination significantly reduces common EGFR and MET resistance mutations seen with …